- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07437781
Chakra Aromatherapy for Nurses (Aromatherapy)
A Randomized Controlled Trial of Chakra-Based Aromatherapy Intervention for Stress Reduction, Mental Well-being, and Sleep Quality in Healthcare Workers
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Taiwan (r.o.c.)
-
New Taipei City, Taiwan (r.o.c.), Taiwan, 24352
- Fu Jen Catholic University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Registered nurses working in hospital settings
- Willing to participate and provide written informed consent
Exclusion Criteria:
- Atopic dermatitis
- Respiratory disease
- Pregnancy or lactation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: experimental group
Chakra-based Aromatherapy: Participants will receive chakra-based aromatherapy using essential oils applied with inhalation and massage, 30 minutes per session, 5 times per week, for 4 weeks.
|
Chakra-based Aromatherapy: Participants will receive chakra-based aromatherapy using essential oils applied with inhalation and massage, 30 minutes per session, 5 times per week, for 4 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
1.Chinese version of the Pittsburgh Sleep Quality Scale 2.Stress index measuring table
Time Frame: 4 weeks
|
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brief Symptom Rating Scale
Time Frame: 4 weeks
|
This scale includes a set of five symptom items. The "suicidal ideation" item is assessed separately, with a score of 6 or higher being the cutoff for screening. The Short Form Health Scale (BSRS-5) asks patients to recall the degree of distress or anxiety they have felt over the past week (including the day of assessment). A total BSRS-5 score of ≤3 may rule out suicidal risk. It is recommended to first inquire about the presence of symptoms, and then determine the severity if present. The BSRS-5 score ranges from 0 to 20, and is categorized into several levels based on the score: <6 points: Normal range, indicating a good mood. 6-9 points: Mild, stress management is recommended; talk to family or friends to express emotions. 10-14 points: Moderate, professional counseling is recommended; seek psychological counseling or receive professional help. 15 points or above: Severe, requires high level of care; seek professional guidance or psychiatric treatment. |
4 weeks
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Thangaleela, S., Sivamaruthi, B. S., Kesika, P., Bharathi, M., Kunaviktikul, W., Klunklin, A., Chanthapoon, C., & Chaiyasut, C. (2022). Essential oils, phytoncides, aromachology, and aromatherapy-A review. Applied Sciences, 12(9), 4495. https://doi.org/10.3390/app12094495
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FJUH113388
- PL-202408015-M (Other Grant/Funding Number: CHUNG HUI TING)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Supportive Therapy
-
Western Michigan UniversityCompletedAcceptance and Commitment Therapy | Supportive Therapy
-
Duke UniversityAstraZenecaCompleted
-
Istituto Auxologico ItalianoCompleted
-
Mansoura UniversityUnknown
-
Gazi UniversityCompletedSupportive CareTurkey (Türkiye)
-
Wake Forest University Health SciencesMedical University of South Carolina; National Cancer Institute (NCI)CompletedSupportive CareUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedCancer | Supportive CareUnited States
-
University Health Network, TorontoCanadian Institutes of Health Research (CIHR)CompletedCancer | Supportive CareCanada
-
Faroese Hospital SystemUniversity of Aarhus; University of the Faroe Islands; The National Hospital...Not yet recruiting
-
Konrad BresinCompletedControl | Supportive MessagesUnited States
Clinical Trials on Aromatherapy
-
Cedars-Sinai Medical CenterRecruitingRhinitis, Vasomotor | Thyroid Nodules | Inferior Turbinate Hypertrophy | Vocal Fold Immobility | Chronic Rhinosinusitis (CRS)United States
-
Postgraduate Institute of Dental Sciences RohtakCompletedPain | Dental AnxietyIndia
-
Tokat Gaziosmanpasa UniversityCompleted
-
Franklin Health ResearchCompletedMorning Sickness | Pregnancy EarlyUnited States
-
Brigham and Women's HospitalCompletedStress | Anxiety | Emergency Department | AromatherapyUnited States
-
Singapore General HospitalNational Cancer Centre, SingaporeEnrolling by invitationChemotherapy-Induced Nausea and Vomiting (CINV)Singapore
-
Mardin Artuklu UniversityCompletedMusic Therapy | AromatherapyTurkey
-
National Cheng-Kung University HospitalActive, not recruitingDementia | SundowningTaiwan